Market Overview

Piper Jaffray Raises PT on Theravance to $35

Piper Jaffray has raised the price target on Theravance (NASDAQ: THRX) from $31 to $35 and maintains its Overweight rating.

Posted-In: Piper JaffrayPrice Target Pre-Market Outlook Analyst Ratings

 

Related Articles (THRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters